Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KOSDAQ - Delayed Quote KRW

GREEN CROSS WellBeing Corporation (234690.KQ)

7,950.00
+120.00
+(1.53%)
As of 2:22:18 PM GMT+9. Market Open.
Loading Chart for 234690.KQ
  • Previous Close 7,830.00
  • Open 7,900.00
  • Bid 7,940.00 x --
  • Ask 7,950.00 x --
  • Day's Range 7,840.00 - 7,960.00
  • 52 Week Range 7,100.00 - 13,870.00
  • Volume 16,178
  • Avg. Volume 73,478
  • Market Cap (intraday) 141.074B
  • Beta (5Y Monthly) 0.70
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield 100.00 (1.07%)
  • Ex-Dividend Date Dec 27, 2023
  • 1y Target Est --

GREEN CROSS WellBeing Corporation provides personalized nutrition injections in South Korea. It offers natural medicines, health functional foods, sports foods, and cosmetics. The company was founded in 2004 and is based in Seongnam-si, South Korea.

www.greencrosswb.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 234690.KQ

View More

Performance Overview: 234690.KQ

Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

234690.KQ
20.97%
KOSPI Composite Index (^KS11)
5.15%

1-Year Return

234690.KQ
21.91%
KOSPI Composite Index (^KS11)
3.81%

3-Year Return

234690.KQ
12.54%
KOSPI Composite Index (^KS11)
6.71%

5-Year Return

234690.KQ
7.89%
KOSPI Composite Index (^KS11)
31.78%

Compare To: 234690.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 234690.KQ

View More

Valuation Measures

Annual
As of 4/22/2025
  • Market Cap

    138.94B

  • Enterprise Value

    169.48B

  • Trailing P/E

    19.67

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.04

  • Price/Book (mrq)

    1.32

  • Enterprise Value/Revenue

    1.27

  • Enterprise Value/EBITDA

    10.03

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.30%

  • Return on Assets (ttm)

    4.33%

  • Return on Equity (ttm)

    6.86%

  • Revenue (ttm)

    126.44B

  • Net Income Avi to Common (ttm)

    6.71B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.76B

  • Total Debt/Equity (mrq)

    44.21%

  • Levered Free Cash Flow (ttm)

    -2.36B

Research Analysis: 234690.KQ

View More

Company Insights: 234690.KQ

Research Reports: 234690.KQ

View More

People Also Watch